Home Applications 208749 Application 208749
Type ANDA
Sponsor MAIA PHARMS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM POWDER;INTRAVENOUS 100MCG/VIAL No No 002 LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM POWDER;INTRAVENOUS 200MCG/VIAL No No 003 LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM POWDER;INTRAVENOUS 500MCG/VIAL No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208749-001 LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 A208749-002 LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 A208749-003 LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 84e616aacf4f…2026-08-18 06:07:40 2026-07 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208749-002 LEVOTHYROXINE SODIUM 200MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208749-003 LEVOTHYROXINE SODIUM 500MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A208749-001 LEVOTHYROXINE SODIUM 100MCG/VIAL POWDER / INTRAVENOUS AP 2018-12-21 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 4 · 129 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 70511-111 Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS MAIA Pharmaceuticals, Inc. ANDA Current 70511-112 Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS MAIA Pharmaceuticals, Inc. ANDA Current 70511-113 Levothyroxine Sodium LEVOTHYROXINE SODIUM ANHYDROUS MAIA Pharmaceuticals, Inc. ANDA Current 70860-451 Levothyroxine Sodium levothyroxine sodium anhydrous Athenex Pharmaceutical Division, LLC. ANDA Current 70860-452 Levothyroxine Sodium levothyroxine sodium anhydrous Athenex Pharmaceutical Division, LLC. ANDA Current 70860-453 Levothyroxine Sodium levothyroxine sodium anhydrous Athenex Pharmaceutical Division, LLC. ANDA Current